Nickerson Joan

CIK 00019644611 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001964461

Recent Transactions

18 trades

Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−225,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−18,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−125,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−6,630→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−102,016→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−40,000→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−17,420→ 0 total
Sale
Verve Therapeutics, Inc.
Common Stock
2025-04-02$4.15/sh−2,777→ 17,420 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2025-04-01−6,000→ 18,000 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2025-04-01+9,315→ 20,197 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Unuits
2025-04-01−3,315→ 6,630 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2025-01-08+40,000→ 40,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-01-08+225,000→ 225,000 total
Sale
Verve Therapeutics, Inc.
Common Stock
2024-04-02$8.24/sh−1,514→ 8,659 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2024-04-01+3,315→ 10,173 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2024-04-01−3,315→ 9,945 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-02-14+125,000→ 125,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2024-02-14+24,000→ 24,000 total

Companies

Verve Therapeutics, Inc.
Chief Administrative Officer

Recent Filings

Address

C/O VERVE THERAPEUTICS, INC. 201 BROOKLINE AVENUE, SUITE 601

BOSTON, MA, 02215

View on SEC.gov